Neurotoxic Amyloidogenic Peptides Identified in the Proteome of SARS-COV2: Potential Implications for Neurological Symptoms in COVID-19
(Hinzugefügt: 25.11.2021 um 12:23 Uhr)
Brain MRI in SARS-CoV-2 pneumonia patients with newly developed neurological manifestations suggestive of brain involvement
(Hinzugefügt: 22.10.2021 um 16:25 Uhr)
SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disruption without tight junctions alteration
(Hinzugefügt: 22.10.2021 um 16:14 Uhr)
Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer’s disease
(Hinzugefügt: 20.09.2021 um 09:22 Uhr)
Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study
(Hinzugefügt: 26.08.2021 um 04:16 Uhr)
Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T cell interactions
(Hinzugefügt: 11.06.2021 um 06:45 Uhr)
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
(Hinzugefügt: 11.06.2021 um 06:37 Uhr)
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19
(Hinzugefügt: 13.05.2021 um 17:33 Uhr)
Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry
(Hinzugefügt: 23.04.2021 um 11:57 Uhr)
First Australian Case of Good Recovery of a COVID-19 Patient With Severe Neurological Symptoms Post Prolonged Hospitalization
(Hinzugefügt: 12.04.2021 um 18:09 Uhr)
Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer’s disease
(Hinzugefügt: 08.04.2021 um 06:24 Uhr)
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records
(Hinzugefügt: 07.04.2021 um 17:55 Uhr)
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
(Hinzugefügt: 23.03.2021 um 09:59 Uhr)
Brain and Lung Imaging Correlation in Patients with COVID-19: Could the Severity of Lung Disease Reflect the Prevalence of Acute Abnormalities on Neuroimaging? A Global Multicenter Observational Study
(Hinzugefügt: 22.03.2021 um 16:24 Uhr)
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
(Hinzugefügt: 06.03.2021 um 07:39 Uhr)
The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning
(Hinzugefügt: 11.01.2021 um 18:54 Uhr)
The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning
(Hinzugefügt: 06.01.2021 um 08:35 Uhr)
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study
(Hinzugefügt: 17.12.2020 um 16:49 Uhr)
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
(Hinzugefügt: 11.12.2020 um 13:11 Uhr)
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
(Hinzugefügt: 30.11.2020 um 19:58 Uhr)
Central and peripheral nervous system complications of COVID-19: A prospective tertiary center cohort with 3-month follow-up
(Hinzugefügt: 18.11.2020 um 09:04 Uhr)